Olmesartan

🧮 Dose calculator

Hypertension · Regimen source: FDA Olmesartan · 2.1

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyDangerous / avoid

  Label: can cause fetal harm. Dangerous in pregnancy. FDA Olmesartan · Boxed Warning

  “WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Olmesartan · 8.2

  “Risk Summary There is no information regarding the presence of olmesartan in human milk, the effects on the breastfed infant, or the effects on milk production. olmesartan is secreted at low concentration in the milk of lactating rats (see Data) .”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Olmesartan · 8.4

  “The antihypertensive effects of olmesartan medoxomil tablets were evaluated in one randomized, double-blind clinical study in pediatric patients 1 to 16 years of age [see Clinical Studies (14.2) ].”

• 👴 Older adultsNo specific problem stated

  Label: no specific difference or dose adjustment stated for older adults. FDA Olmesartan · 8.5

  “No overall differences in effectiveness or safety were observed between elderly patients and younger patients.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.